Further work is required to determine the extent of dysregulated IFN signaling in CF (e.g., does it extend to other immune cells and epithelial cells as previous studies suggest) and to elucidate the full extent to which this phenotype affects the optimal immune response to viral and bacterial infection. This evidence concerns the gene IFNA1 and cystic fibrosis.